Chronic lymphocytic leukaemia: open trials in Norway

• NCT06136559

  A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Akershus University Hospital, Loerenskog · Oslo University Hospital HF, Oslo · Sykehuset I Vestfold HF, Toensberg

  Registry updated 2026-10-13

• 2023-510294-34-00

  A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (15 cycles) venetoclax/ pirtobrutinib vs. MRD-guided venetoclax/ pirtobrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL) aiming to establish measurement of individual residual disease for adjustment of treatment duration to improve outcomes (CLL18/ MOIRAI)

  Trial Treatment · Phase 3 · University Of Cologne

  Helse Bergen HF, Bergen · Akershus University Hospital, Loerenskog · St. Olavs hospital HF, Trondheim

  Registry updated 2026-10-01

• NCT04771507

  A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)

  Trial Treatment · Phase 1/2 · Jeanette Lundin

  St Olavs Hospital, Trondheim

  Registry updated 2021-02-25

All Chronic lymphocytic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error